Vascular myelopathy
| Vascular myelopathy | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Weakness, numbness, paralysis, pain |
| Complications | Paraplegia, urinary incontinence, bowel dysfunction |
| Onset | |
| Duration | |
| Types | |
| Causes | Ischemia, hemorrhage, arteriovenous malformation |
| Risks | Atherosclerosis, hypertension, diabetes mellitus |
| Diagnosis | MRI, spinal angiography |
| Differential diagnosis | Multiple sclerosis, transverse myelitis, spinal cord tumor |
| Prevention | Control of risk factors |
| Treatment | Surgery, anticoagulation, steroids |
| Medication | |
| Prognosis | Variable, depends on cause and treatment |
| Frequency | Rare |
| Deaths | N/A |
UCLPartners is an academic health science partnership with over 40 higher education and NHS members. It is one of the largest academic health science centres in the world and is based in London, United Kingdom. UCLPartners was officially designated as one of the UK's first academic health science centres by the UK Department of Health in March 2009.
History[edit]
UCLPartners was established in 2009 with the aim of translating cutting-edge research and innovation into measurable health gain for patients and populations in London, across the UK and globally. The partnership brings together some of the UK's largest NHS trusts and universities.
Members[edit]
UCLPartners includes the following members:
- University College London
- Great Ormond Street Hospital for Children NHS Trust
- Moorfields Eye Hospital NHS Foundation Trust
- Royal Free London NHS Foundation Trust
- University College London Hospitals NHS Foundation Trust
Research and Development[edit]
UCLPartners has a strong focus on research and development. The partnership supports a broad range of clinical and translational research, with a particular focus on neuroscience, cancer, cardiovascular disease, child health, and infection, immunity and inflammation.
Education and Training[edit]
UCLPartners also provides a range of education and training opportunities for healthcare professionals, including postgraduate medical training, specialist training and continuing professional development.
External Links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
